Advantage Alpha Capital Partners’s OrthoPediatrics KIDS Stock Holding History

Advantage Alpha Capital Partners’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-51,047	Closed	-$2.76M	–	117
2022 Q1	$2.76M	Buy	+51,047	New	+$2.61M	0.41%	86
2021 Q4	–	Sell	-42,879	Closed	-$2.81M	–	134
2021 Q3	$2.81M	Sell	42,879 -4,172	-9%	-$271K	0.51%	87
2021 Q2	$2.97M	Sell	47,051 -6,279	-12%	-$361K	0.57%	81
2021 Q1	$2.6M	Buy	53,330 +3,704	+7%	+$178K	0.55%	82
2020 Q4	$2.05M	Buy	+49,626	New	+$2.28M	0.45%	86

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Advantage Alpha Capital Partners's KIDS Position: Q2 2022 in Review

Advantage Alpha Capital Partners sold out of OrthoPediatrics (KIDS) in Q2 2022, closing a stake of 51,047 shares — an estimated $2.76M sold.

Advantage Alpha Capital Partners first reported a position in KIDS in Q4 2020 and held it in 5 quarters. The position peaked at $2.97M in Q2 2021. 117 funds tracked by Wall St. Rank hold KIDS as of Q2 2022.

Advantage Alpha Capital Partners reported no remaining OrthoPediatrics position as of Q2 2022 after selling out during the quarter.
Advantage Alpha Capital Partners sold 51,047 OrthoPediatrics shares in Q2 2022, an estimated $2.76M.
Advantage Alpha Capital Partners first reported a position in OrthoPediatrics in Q4 2020 and held it in 5 quarters.
Advantage Alpha Capital Partners's OrthoPediatrics position peaked at $2.97M in Q2 2021.
117 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2022.

Based on Advantage Alpha Capital Partners's 13F filing for Q2 2022, filed 12 Aug 2022.